Literature DB >> 17696748

Cost effectiveness of cervical cancer screening among Chinese women in North America.

Beti Thompson1, Anne L Thompson, Nadine L Chan, Gregory T Hislop, Vicky M Taylor.   

Abstract

BACKGROUND: Chinese North American women have high invasive cervical cancer rates and low screening rates. The cost-effectiveness of strategies to improve Pap testing rates for Chinese women living in Seattle, Washington and Vancouver, British Columbia was examined.
OBJECTIVES: To calculate the costs and cost-effectiveness of implementing two strategies to motivate women to obtain a Pap smear. RESEARCH
DESIGN: A three-armed randomized, controlled trial was conducted. Women in each of two interventions (high-intensity outreach and low-intensity mailing intervention) were compared to a group of women who received usual care. MEASURES: Costs were captured via a group discussion of costs, accounting records, sampling of staff time logs, and estimation of costs and task times. Effectiveness was measured as the proportion of women in each intervention arm who reported receiving a Pap smear since the trial began. Cost-effectiveness was calculated as the incremental cost of screening each additional woman between an intervention arm and the control arm.
RESULTS: A greater percentage of women who received the outreach intervention had a Pap test than women who received mailed materials or women who were in the usual care arm. The intent-to-treat cost for each additional woman to be screened for a Pap test was $415 in the Outreach arm and $676 for the Direct Mailing arm. The outreach worker intervention, though more expensive overall, was more cost-effective than the mailing intervention.
CONCLUSIONS: Outreach intervention is cost-effective for sponsors and should be considered as a strategy to motivate Chinese women living in North America to seek cervical cancer screening.

Entities:  

Mesh:

Year:  2007        PMID: 17696748

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Cost effectiveness of a program to promote screening for cervical cancer in the Vietnamese-American population.

Authors:  John F Scoggins; Scott D Ramsey; J Carey Jackson; Victoria M Taylor
Journal:  Asian Pac J Cancer Prev       Date:  2010

2.  Cervical cancer screening with AMIGAS: a cost-effectiveness analysis.

Authors:  David R Lairson; Yu-Chia Chang; Theresa L Byrd; Judith Lee Smith; Maria E Fernandez; Katherine M Wilson
Journal:  Am J Prev Med       Date:  2014-06       Impact factor: 5.043

3.  Breast and Cervical Cancer Screening Literacy Among Korean American Women: A Community Health Worker-Led Intervention.

Authors:  Hae-Ra Han; Youngshin Song; Miyong Kim; Haley K Hedlin; Kyounghae Kim; Hochang Ben Lee; Debra Roter
Journal:  Am J Public Health       Date:  2016-11-17       Impact factor: 9.308

4.  Economic evaluation of a community health worker-led health literacy intervention to promote cancer screening among Korean American women.

Authors:  Anne L Schuster; Kevin D Frick; Bo-Yun Huh; Kim B Kim; Miyong Kim; Hae-Ra Han
Journal:  J Health Care Poor Underserved       Date:  2015-05

5.  Economics of Multicomponent Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening: A Community Guide Systematic Review.

Authors:  Giridhar Mohan; Sajal K Chattopadhyay; Donatus U Ekwueme; Susan A Sabatino; Devon L Okasako-Schmucker; Yinan Peng; Shawna L Mercer; Anilkrishna B Thota
Journal:  Am J Prev Med       Date:  2019-08-30       Impact factor: 5.043

6.  Evaluation of a hepatitis B lay health worker intervention for Chinese Americans and Canadians.

Authors:  Vicky M Taylor; T Gregory Hislop; Shin-Ping Tu; Chong Teh; Elizabeth Acorda; Mei-Po Yip; Erica Woodall; Yutaka Yasui
Journal:  J Community Health       Date:  2009-06

Review 7.  A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women.

Authors:  Mingshan Lu; Sabina Moritz; Diane Lorenzetti; Lindsay Sykes; Sharon Straus; Hude Quan
Journal:  BMC Public Health       Date:  2012-06-07       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.